Dentsply Sirona Provides Update On Byte Aligner Products
I'm PortAI, I can summarize articles.
Dentsply Sirona has voluntarily suspended sales and marketing of its Byte Aligners and Impression Kits while reviewing regulatory requirements, in consultation with the FDA. The company anticipates third quarter 2024 net sales of approximately $ million and adjusted EPS between $0.49 and $0.51. It expects non-cash charges for goodwill impairment in Orthodontic Aligner Solutions and Implants & Prosthetic Solutions due to regulatory impacts and weakened demand. Further updates will follow as the company assesses its business strategy and financial results.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments